Skip to main content

Biotechnology Articles

  • EMERGENCE OF NOVEL PEPTIDE MOLECULAR CLASS AS ANTIBIOTICS

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS
    Akansha Bhandari1, Nitisha Bhandari2*
    1
    Department of Lifesciences,
    Shri Guru Ram Rai Institute of Technology and Science, Patel Nagar, Dehradun, India
    2 Department of Biotechnology, Graphic Era University, Dehradun, India
    *nitishabhandari89@gmail.com

    ABSTRACT
    Modern era diseases bring more challenges and hurdles to the rational drug targeting. However chemotherapy is the most affected area as most reports are related to antibiotics resistance. Although some successes are accounted as new molecules and new structures are keep on synthesizing or either isolated. One such example is Teixobactin which is isolated for Eleftheria terrae, which was found to be active against Staphylococcus and Mycobacterium bacteria. The story of Teixobactin isolation could open new horizon and opportunistic ways for future designing of useful drugs against these resistance bacteria. In the similar context we tried to compile the relevant paper that was published in nature in 2015 into a commentary based critical review.

  • EXTRACTION AND PURIFICATION OF NUCLEIC ACID USING CBNP & PCIA TECHNIQUE

    { DOWNLOAD AS PDF }

    About Author
    Nirav Soni
    Department of Quality Assurance,
    A-One Pharmacy College,
    Anasan, Ahmedabad, Gujarat, India
    nirav_sonic@yahoo.com

    ABSTRACT
    Isolation of Nucleic acid easily by Solid Phase Extraction (SPE) and this approach, using commercially available Extraction of nucleic acid column-based kits, requires no toxic chemicals and is a rapid and consistent method for concomitant protein extraction. It is a modern technique useful for separation of Nucleic acid which is  most reliable, less time consuming and separation of  impurities and continuity of reactive products using listed techniques like column-based nucleic acid purification, Nucleic acid methods& ethanol precipitation, DNA separation by silica adsorption. Buffer choice is significant to completely solubilized all proteins in the sample. This technique provides a simple and effective way to analyze protein and nucleic acids simultaneously from the same sample not affecting yield and quality.

  • BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS: ABOUT ITS STABILITY TESTING

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS
    Vivek P. Chavda1*, Dharmesh Shaliya2, Bhargav Patel3, Ashish Gabani4
    1Department of Pharmaceutics, B.K. Mody Government Pharmacy College, Rajkot, Gujarat, India
    2Quality Assurance, Intas Pharmaceuticals Ltd., Ahmedabad, Gujarat, India
    3Quality Assurance, Zydus cadila pharmaceuticals Ltd., Ahmedabad, Gujarat, India
    4 Intas Biopharmaceuticals Ltd., Ahmedabad, Gujarat, India

    * vivek7chavda@gmail.com

    ABSTRACT
    The drug delivery systems have made some of the technological advances especially in the case of biopharmaceuticals. When one talks about biotechnological product stability of drug product becomes main culprit due to dynamic nature of drug molecule. This review is grafted using ICH and other regulatory guidelines to provide an overview to stability testing of such molecules.

  • RNA INTERFERENCE-WEAPON AGAINST CANCER

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS:
    Shalja Verma, Anand Kumar Pandey*
    Department of Biotechnology, Institute of Engineering & Technology,
    Bundelkhand University, Jhansi, Uttar Pradesh, India
    vnsanand_9@rediffmail.com

    ABSTRACT
    Cancer is the second principal death cause, in the recent scenario 1 out of every 4 people die out of cancer. Not more than 50% advanced cancer subjects live a year ahead. RNA interference (RNAi) a phenomenon which serves for shutting off the expression of a specific sequence has proved itself a finest weapon against cancer. This mechanism involves silencing of the expression of desired mRNA sequence by degrading it using a dsRNA (double stranded RNA) molecule having complementarity to the desired mRNA. However a major challenge in proficient implementation of this therapy against cancer is lack of efficient delivery methods for the dsRNA to the target tissue. Various delivery methods had already been developed for efficient and effective delivery of the dsRNA and many are under trial. This review is going to present the great efficacy of RNAi against cancer and the various delivery methods performing capable work in accurate application of this therapy.

  • BREAKTHROUGHS IN EPIGENETICS

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS:
    Shashi Shekhar Anand, Navgeet, Balraj Singh Gill*
    Centre for Biosciences,
    School of Basic and Applied Sciences,
    Central University of Punjab, Bathinda, India
    gillsinghbalraj@gmail.com

    ABSTRACT
    The word ‘epigenetic’ was first coined by Conrad Waddington in 1946. It deals with functionally relevant modifications to the genome that do not include a change in the nucleotide sequence. Till date observation has focused on the functions of genome sequences and how their regulation occurs. The emerging epigenetic changes and the interactions between cis-acting elements with protein factors  plays a central role in gene regulation as well as give insight to various diseases. To evaluate the crosstalk of DNA and protein by taking account of the whole genome, one new evolving technique which is called as ChIP-chip, works on the principle of combining chromatin immunoprecipitation with microarray. ChIP-chip has been recently used in basic biological studies and may be improved further and can be useful for other to aspects, like human diseases. Now a days large amount of discoveries by ChIP-chip and other high-throughput techniques like this   may be connected with evolving bioinformatics to add to our knowledge of life and diseases.

  • A REVIEW ON SINGLE USE DISPOSABLE TECHNOLOGY FOR RECOMBINANT PROTEIN MANUFACTURING

    ABOUT AUTHOR
    Madhusudan P Dabhole
    Group Manager – BioProcess,
    Richcore Life Sciences Ltd, Bangalore, Karnataka, India
    madhav888@rediffmail.com

    ABSTRACT
    The manufacturing of recombinant products by fermentation and purification in stainless steel vessels has seen the transition from small scale to large scale and further to single use disposable technology. The requirement to develop and modulate the process has arisen from the cost and manufacturers need to move the facility on mobile platforms. The review describes the strategies and considerations for Single Use Disposable Technology. Recombinant proteins are widely used for treatment of various diseases and disorders. Single Use Disposable Technology makes it promising to produce and formulate these proteins from bench scale to commercial level in a shorter span of time so that it can reach the physician and patients.

  • COMPARATIVE EVALUATION OF PURIFICATION METHODS FOR PRODUCTION OF POLYPEPTIDE ANTIBIOTICS – “POLYMYXIN B” AND “CEREXIN A” FROM BACILLUS SPECIES

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS:
    Pratyush Kumar Das1, Shilpa Das1, Debasish Sahoo2, Jikasmita Dalei2, V.Madhav Rao2, Sunakar Nayak2, Swadhin Palo3
    1Centre of Biotechnology, Siksha O Anusandhan University, Bhubaneswar, Odisha, India.
    2Nitza Biologicals (P.) Ltd.Chandra Towers, Near Fortune Honda Showroom, Neredmet 'X' Road, Secundrabad, Andhra Pradesh, India.
    3Roland Institute of Pharmaceutical Sciences, Berhampur, Odisha, India.
    onlypratyush11@gmail.com

    ABSTRACT:
    Polymyxin B and Cerexin A are two polypeptide antibiotics, the first one discovered and incorporated quite earlier and the later one has still not been used in clinical trials for its high cytotoxic nature. Although Polymyxin was discovered very earlier but in the mid-way for some time it had lost its importance and was not used frequently due to its narrow spectra of action that only acts on gram negative microbes and because of its toxicity level. But with several new resistant gram negative microbes coming into the limelight responsible for causing many infections, Polymyxin B (the least toxic of all Polymyxins) has again been started to be used in pharmaceutical formulations and drugs. In this project, both Bacillus polymyxa and Bacillus cereus responsible for production of Polymyxin B and Cerexin A respectively were isolated from the rhizosphere of grass and cultured in the lab. They were confirmed by biochemical tests and then used to produce the corresponding antibiotics by submerged fermentation. The crude antibiotic thus obtained were purified by various methods like adsorption through activated charcoal, acetone precipitation, dialysis, Ion Exchange and Sephadex column chromatography and the results were compared to find the best possible way to purify the antibiotics keeping in mind that they show the maximum activity as possible on a lab scale. Further work on Cerexin A was not possible due to the unavailability of its standard solution. Work was carried out for quantitative estimation of purified and crude Polymyxin B by performing spectrophotometric assay against standard polymyxin.

  • DNA MICROSATELLITES: A REVIEW

    { DOWNLOAD AS PDF }

    About Authors:
    Shikha Jain*, Ranjana Joshi, Kirti Jatwa, Avnish Sharma, S.C. Mahajan
    Department of Pharmaceutics,
    Mahakal Institite of Pharmaceutical Studies,
    Behind Air strip, Datana, Dewas Road, Ujjain, M.P.
    jain.shikhapharma@gmail.com

    Abstract
    Microsatellites consist of tandemly repeated sequence, no more than 6 bases long. They are scattered throughout most eukaryotic genomes. The major characteristic that makes microsatellites as useful and powerful genetic tool is the extensive length polymorphism that first of all reflects allelic variation in the number of the tandemly arranged perfect repeats. Microsatellite are generally considered as the most powerful genetic marker.
    A genetic marker is a gene or DNA sequence with a known location on a chromosome that can be used to identify individuals or species. Genetic marker that reveal polymorphisms at the DNA level are called molecular marker.
    Molecular markers are called as DNA markers, which should be thought of as signs along the DNA trail that pinpoint the location of desirable genetic traits or indicate specific genetic differences.They are responsible for various neurological diseases and hence the same cause can now be utilized for the early detection of various diseases, such as, Schizophrenia, Bipolar Disorder and Congenital generalized Hypertrichosis . These agents are widely used for forensic identification and relatedness testing, and are predominant genetic markers in this area of application.

  • BIOTECHNOLOGY FOR A BETTER WORLD

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS:
    Nirav.R. Soni
    M.Pharm, A-One Pharmacy College,
    Anasan, Ahmedabad-382330, India
    nirav_sonic@yahoo.com

    ABSTRACT:
    Pharmaceutical Biotechnology is not a source of energy, but a scientific method that provides tools to produce energy based entirely on modern biotechnological techniques, as to date encompass a wider range of altogether newer medicinal compounds, e.g., antibiotics, vaccines development and monoclonal antibodies (MABs) that may now be produced commercially using well-defined, optimized and improved fermentative methodologies. In fact, genetic engineering has brought in a sea change by virtue of the directed construction of microorganisms resulting in a plethora of newer life-saving drugs. Focus on a variety of  Research areas including health/medicine, food science, environmental science and agri- science and also bioenergy development.

  • DRUG DESIGNING : A REVIEW

    ABOUT AUTHOR:
    Muhammed Mujahed
    Master’s of Science in Biotechnology.
    SRTM University.
    mujubiotech2011@rediffmail.com

    INTRODUCTION:
    Drug design is an integrated developing discipline which portends an era of ‘tailored drug’. It involves the study of effects of biologically active compounds on the basis of molecular interactions in terms of molecular structure or its physico-chemical properties involved. It studies the processes by which the drug produce their effects, how they react with the protoplasm to elicit a particular pharmacological effect or response how they are modified or detoxified, metabolized or eliminated by the organism.

    Disposition of drugs in individual region of biosystems is one of the main factors determining the place , mode and intensity of their action . The biological activity may be “positive” as in drug design or “negative” as in toxicology. Thus drug design involves either total innovation of lead  or an optimization of already available lead. These concepts are the building stones up on which the edifice of drug design is built up.

    The drug is most commonly an organicsmall  molecule that activates or inhibits the function of a biomolecule such as a protein, which in turn results in a therapeutic benefit to the patient. In the most basic sense, drug design involves the design of small molecules that are complementary in shape and charge to the biomolecular target with which they interact and therefore will bind to it. Drug design frequently but not necessarily relies on computer modeling techniques. This type of modeling is often referred to as computer-aided drug design. Finally, drug design that relies on the knowledge of the three-dimensional structure of the biomolecular target is known as structure-based drug design.

Subscribe to Biotechnology Articles